Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration.
Gordon AJ, Saxon AJ, Kertesz S, Wyse JJ, Manhapra A, Lin LA, Chen W, Hansen J, Pinnell D, Huynh T, Baylis JD, Cunningham FE, Ghitza UE, Bart G, Yu H, Sauer BC. Gordon AJ, et al. Among authors: cunningham fe. Drug Alcohol Depend. 2023 Jul 1;248:109902. doi: 10.1016/j.drugalcdep.2023.109902. Epub 2023 May 2. Drug Alcohol Depend. 2023. PMID: 37196572
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomes.
Bajema KL, Berry K, Streja E, Rajeevan N, Li Y, Yan L, Cunningham F, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Osborne TF, Viglianti EM, Aslan M, Huang GD, Ioannou GN. Bajema KL, et al. medRxiv [Preprint]. 2022 Dec 16:2022.12.05.22283134. doi: 10.1101/2022.12.05.22283134. medRxiv. 2022. PMID: 36561190 Free PMC article. Updated. Preprint.
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes.
Bajema KL, Berry K, Streja E, Rajeevan N, Li Y, Mutalik P, Yan L, Cunningham F, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Osborne TF, Viglianti EM, Aslan M, Huang GD, Ioannou GN. Bajema KL, et al. Ann Intern Med. 2023 Jun;176(6):807-816. doi: 10.7326/M22-3565. Epub 2023 Jun 6. Ann Intern Med. 2023. PMID: 37276589 Free PMC article. Clinical Trial.
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation.
Ioannou GN, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, Bui D, Cunningham F, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Osborne TF, Viglianti EM, Aslan M, Huang GD, Bajema KL. Ioannou GN, et al. Ann Intern Med. 2023 Nov;176(11):1486-1497. doi: 10.7326/M23-1394. Epub 2023 Oct 31. Ann Intern Med. 2023. PMID: 37903369 Free PMC article.
Pharmacogenetic testing and monitoring of complete blood counts among Veterans newly prescribed thiopurine treatments: a retrospective cohort study.
Chang NN, Chanfreau-Coffinier C, Bates J, Tuteja S, Anglin TR, Moore VR, Hou J, Waljee A, Pridgen KM, Oslin DW, Voora D, DuVall SL, Cunningham FE, Lynch JA. Chang NN, et al. Among authors: cunningham fe. J Pharm Policy Pract. 2023 Dec 11;16(1):166. doi: 10.1186/s40545-023-00657-7. J Pharm Policy Pract. 2023. PMID: 38082299 Free PMC article.
ASHP and ASHP Foundation Pharmacy Forecast 2024: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems.
DiPiro JT, Hoffman JM, Schweitzer P, Chisholm-Burns MA, Nesbit TW, Fabian TJ, Cunningham FE, Barrett A, Fine MJ, Tichy E, Hernandez I, Scott CM, Norman C, Nelson SD, Kumah-Crystal Y. DiPiro JT, et al. Among authors: cunningham fe. Am J Health Syst Pharm. 2024 Jan 5;81(2):5-36. doi: 10.1093/ajhp/zxad231. Am J Health Syst Pharm. 2024. PMID: 38048298
80 results